58670 Federal Register / Vol. 72, No.
199 / Tuesday, October 16, 2007 / Notices
recommend improvements in the
national newborn and childhood
heritable screening programs, and to
engage in the following activities:
(1) Provide advice and
recommendations to the Secretary
concerning grants and projects awarded
or funded under its designated
authorizing PHS Act;
(2) Provide technical information to
the Secretary for the development of
policies and priorities for the
administration of grants under the
designated PHS act; and
(3) Provide such recommendations,
advice or information as may be
necessary to enhance, expand or
improve the ability of the Secretary to
reduce the mortality or morbidity in
newborns and children from heritable
disorders.
The purpose of this call is to hear
discussion from the ACHDGDNC
members on the proposed review
template from the ACHDGDNC’s
Evidence Workgroup and, if the
ACHDGDNC chooses, to approve that
template. In addition, the ACHDGDNC
may choose to develop
recommendations from the ACHDGDNC
to the Secretary concerning the
ACHDGDNC’s evaluation and
decisionmaking process and newborn
screening long-term followup.
Dated: October 9, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review
and Coordination.
[FR Doc. E7–20387 Filed 10–15–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the President’s Cancer
Panel, October 22, 2007, 8 a.m. to
October 22, 2007, 6:30 p.m., Hyatt
Regency La Jolla, 3777 La Jolla Village
Drive, San Diego, CA 92122 which was
published in the Federal Register on
September 26, 2007, 72 FR 54667.
This meeting is being amended to
reschedule the closed session to
Tuesday, October 30, 2007, 2 p.m.–4
p.m., as a telephone conference. The
meeting is closed to the public.
Dated: October 5, 2007.
mmaher on PROD1PC70 with NOTICES
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5093 Filed 10–15–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005 04:12 Oct 16, 2007 Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: November 15–16, 2007.
Time: November 15, 2007, 8 a.m. to 6 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Review
Group(s); and Budget Presentation; Reports of
Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6th Floor,
Conference Room 10, Bethesda, MD 20892.
Time: November 16, 2007, 8:30 a.m. to 1
p.m.
Agenda: Reports of Special Initiatives; RFA
and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6th Floor,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD,
Executive Secretary, Director, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, RM. 8001,
Bethesda, MD 20892, 301–496–5147,
grayp@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic
Assistance Program Nos. 93.392, Cancer
Construction; 93.393, Cancer Cause and
Prevention Research; 93.394, Cancer
Detection and Diagnosis Research;
93.395, Cancer Treatment Research;
93.396, Cancer Biology Research;
93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of
Health, HHS)
Dated: October 10, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5095 Filed 10–15–07; 8:45 am]
BILLING CODE 4140–01–M
PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\16OCN1.SGM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
Conference Grant SEP.
Date: October 31, 2007.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Room—1087, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Steven Birken, PhD,
Scientific Review Administrator, Office of
Review, National Center for Research
Resources, National Institutes of Health, 6701
Democracy Blvd., 10th Fl., Bethesda, MD
20892, (301) 435–1078,
birkens@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
C.O.B.R.E.—SEP.
Date: November 1, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Linda C. Duffy, PhD,
Scientific Review Administrator, Office of
Review, National Center for Research
Resources, National Institutes of Health, 6701
Dem. Blvd., 1 Dem, Plaza, Rm. 1082, MSC
4874, Bethesda, MD 20892–4874, 301–435–
0810, duffyl@mail.nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
Comparative Medicine SEP.
Date: November 7, 2007.
Time: 2:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
16OCN1
 Federal Register / Vol. 72, No. 199 / Tuesday, October 16, 2007 / Notices
Boulevard, Room—1087, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Steven Birken, PhD,
Scientific Review Administrator, National
Center for Research Resources, or National
Institutes of Health, 6701 Democracy
Boulevard, One Democracy Plaza, Room
1078, MSC 4874, Bethesda, MD 20892–4874,
301–435–0815, birkens@mail.nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
CM SEP 08’.
Date: November 19, 2007.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 1
Democracy Plaza, 6701 Democracy Blvd.,
1087, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Steven Birken, PhD,
Scientific Review Administrator, National
Center for Research Resources, or National
Institutes of Health, 6701 Democracy
Boulevard, One Democracy Plaza, Room
1078, MSC 4874, Bethesda, MD 20892–4874,
301–435–0815, birkens@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS)
Dated: October 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5089 Filed 10–15–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Sickle Cell Disease Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: October 29, 2007.
mmaher on PROD1PC70 with NOTICES
Time: 8:30 a.m. to 4 p.m.
Agenda: Discussion of Programs and
Issues.
Place: National Institutes of Health, 6701
Rockledge Drive, Conference Room 9112/
9116, Bethesda, MD 20892.
VerDate Aug<31>2005 04:12 Oct 16, 2007 Jkt 214001
Contact Person: Robert B Moor, PhD,
Health Scientist Administrator, Blood
Diseases Program, Division of Blood Disease
and Resources, National Heart, Lung, and
Blood Institute, NIH, 6701 Rockledge Drive,
Room 10162, Bethesda, MD 20892, 301/435–
0050.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 933.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 3, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5084 Filed 10–15–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; MBRS Support of Competitive
Research.
Date: October 23–24, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Margaret J Weidman, PhD,
Office of Scientific Review, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, Room
3AN18B, Bethesda, MD 20892, 301 594–
3663, weidmanma@nigms.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\16OCN1.SGM
58671
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: October 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5083 Filed 10–15–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer
Pathogenesis.
Date: October 24, 2007.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20814 (Telephone
Conference Call).
Contact Person: William Cruce, PhD,
Health Scientist Administrator, Scientific
Review Office, National Institute on Aging,
National Institutes of Health, Room 2C212,
7201 Wisconsin Avenue, Bethesda, MD
20814, 301–402–7704, crucew@nia.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
16OCN1